These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20156515)

  • 1. The role of zinc in neurodegenerative inflammatory pathways in depression.
    Szewczyk B; Kubera M; Nowak G
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):693-701. PubMed ID: 20156515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc and depression. An update.
    Nowak G; Szewczyk B; Pilc A
    Pharmacol Rep; 2005; 57(6):713-8. PubMed ID: 16382189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders.
    Gardner A; Boles RG
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):730-43. PubMed ID: 20691744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids, cytokines and brain abnormalities in depression.
    Zunszain PA; Anacker C; Cattaneo A; Carvalho LA; Pariante CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):722-9. PubMed ID: 20406665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines: abnormalities in major depression and implications for pharmacological treatment.
    O'Brien SM; Scott LV; Dinan TG
    Hum Psychopharmacol; 2004 Aug; 19(6):397-403. PubMed ID: 15303243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc in the Glutamatergic Theory of Depression.
    Mlyniec K
    Curr Neuropharmacol; 2015; 13(4):505-13. PubMed ID: 26412070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc: the new antidepressant?
    Levenson CW
    Nutr Rev; 2006 Jan; 64(1):39-42. PubMed ID: 16491668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?
    Catena-Dell'Osso M; Bellantuono C; Consoli G; Baroni S; Rotella F; Marazziti D
    Curr Med Chem; 2011; 18(2):245-55. PubMed ID: 21110802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?
    Młyniec K; Singewald N; Holst B; Nowak G
    J Affect Disord; 2015 Mar; 174():89-100. PubMed ID: 25490458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc supplementation combined with antidepressant drugs for treatment of patients with depression: a systematic review and meta-analysis.
    da Silva LEM; de Santana MLP; Costa PRF; Pereira EM; Nepomuceno CMM; Queiroz VAO; de Oliveira LPM; Machado MEPDC; de Sena EP
    Nutr Rev; 2021 Jan; 79(1):1-12. PubMed ID: 32885249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ozone exposure of Flinders Sensitive Line rats is a rodent translational model of neurobiological oxidative stress with relevance for depression and antidepressant response.
    Mokoena ML; Harvey BH; Viljoen F; Ellis SM; Brink CB
    Psychopharmacology (Berl); 2015 Aug; 232(16):2921-38. PubMed ID: 25877744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.
    Maes M; Yirmyia R; Noraberg J; Brene S; Hibbeln J; Perini G; Kubera M; Bob P; Lerer B; Maj M
    Metab Brain Dis; 2009 Mar; 24(1):27-53. PubMed ID: 19085093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in zinc homeostasis in depression and antidepressant therapy.
    Nowak G
    Pol J Pharmacol; 1998; 50(1):1-4. PubMed ID: 9662732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate hypothesis of depression and its consequences for antidepressant treatments.
    Musazzi L; Treccani G; Popoli M
    Expert Rev Neurother; 2012 Oct; 12(10):1169-72. PubMed ID: 23082730
    [No Abstract]   [Full Text] [Related]  

  • 15. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
    Yang C; Bosker FJ; Li J; Schoevers RA
    BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.
    Pitsillou E; Bresnehan SM; Kagarakis EA; Wijoyo SJ; Liang J; Hung A; Karagiannis TC
    Mol Biol Rep; 2020 Jan; 47(1):753-770. PubMed ID: 31612411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of magnesium and zinc in depression: similarities and differences.
    Szewczyk B; Szopa A; Serefko A; Poleszak E; Nowak G
    Magnes Res; 2018 Aug; 31(3):78-89. PubMed ID: 30714573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.
    Fakhoury M
    Mol Neurobiol; 2016 Jul; 53(5):2778-2786. PubMed ID: 25823514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential roles of zinc in the pathophysiology and treatment of major depressive disorder.
    Swardfager W; Herrmann N; McIntyre RS; Mazereeuw G; Goldberger K; Cha DS; Schwartz Y; Lanctôt KL
    Neurosci Biobehav Rev; 2013 Jun; 37(5):911-29. PubMed ID: 23567517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziziphi spinosae lily powder suspension in the treatment of depression-like behaviors in rats.
    Wang Y; Huang M; Lu X; Wei R; Xu J
    BMC Complement Altern Med; 2017 Apr; 17(1):238. PubMed ID: 28454575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.